Joseph Edelman, 10% Owner: Acrivon Therapeutics ACRV Sell · Filed 25/04/29

Trade details

Type: Insider sale
Amount: $2,056,604.55
Shares · price: 1,054,669 sh · $1.95 a share
Held after: 4,306,189 sh
Stock: Acrivon Therapeutics ACRV
Person: Joseph Edelman10% Owner
Trade date: 25/04/25
Filed: 25/04/29
Days to filing: 4 days

Sold 19.7% of holdings

Share of holding sold: 19.7%

Acrivon Therapeutics trades, last 26 weeks

What else happened in Acrivon Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/26~25/05/25

Joseph Edelman's recent trades

Joseph Edelman10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$111.5K
28,597 sh
$111.5K
Filed 25/11/13
Traded 25/11/13
Joseph Edelman10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$31.9K
7,862 sh
$31.9K
Filed 25/11/13
Traded 25/11/12
Joseph Edelman10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$20.6K
4,783 sh
$20.6K
Filed 25/11/13
Traded 25/11/11
Joseph Edelman10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$12.5K
3,213 sh
$12.5K
Filed 25/11/13
Traded 25/11/13
Joseph Edelman10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$2,314
537 sh
$2,314
Filed 25/11/13
Traded 25/11/11